Clover Health Investments Corp
NASDAQ:CLOV

Watchlist Manager
Clover Health Investments Corp Logo
Clover Health Investments Corp
NASDAQ:CLOV
Watchlist
Price: 2.99 USD 0.34% Market Closed
Market Cap: 1.5B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one CLOV stock under the Base Case scenario is 3.39 USD. Compared to the current market price of 2.99 USD, Clover Health Investments Corp is Undervalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLOV Relative Value
Base Case
3.39 USD
Undervaluation 12%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
29
vs Industry
57
Median 3Y
0.3
Median 5Y
0.4
Industry
2.2
Forward
0.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-4.7
Industry
22.1
Forward
-23.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
4
Median 3Y
-4.9
Median 5Y
-6.5
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
7
Median 3Y
-4.8
Median 5Y
-5.6
Industry
19.7
More Details
4.5
P/B
P/B
Price to Book Value
4.5
vs History
27
vs Industry
13
Median 3Y
1.9
Median 5Y
2.1
Industry
2.1
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
27
vs Industry
60
Median 3Y
0.1
Median 5Y
0.1
Industry
2.4
Forward
0.7
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
54
Median 3Y
-1
Median 5Y
-2.6
Industry
11.6
Forward
23.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
51
Median 3Y
-1
Median 5Y
-2.6
Industry
15.7
Forward
-38.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
6
Median 3Y
-1.1
Median 5Y
-3.6
Industry
13.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
8
Median 3Y
-1.1
Median 5Y
-3.6
Industry
17.3
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
30
vs Industry
15
Median 3Y
0.5
Median 5Y
1.3
Industry
1.8
More Details

Multiples Across Competitors

CLOV Competitors Multiples
Clover Health Investments Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Clover Health Investments Corp
NASDAQ:CLOV
1.5B USD 1 -60.3 -59.1 -55.5
US
UnitedHealth Group Inc
NYSE:UNH
277.9B USD 0.7 12.6 8.4 9.4
US
Anthem Inc
LSE:0HG8
100.9B USD 0.6 17.1 11.6 13.5
US
Elevance Health Inc
NYSE:ELV
86.6B USD 0.5 14.6 10.3 11.9
US
Humana Inc
NYSE:HUM
28B USD 0.2 16.4 8 10.1
US
Centene Corp
NYSE:CNC
27.6B USD 0.2 8 5.9 7.9
US
Molina Healthcare Inc
NYSE:MOH
16B USD 0.4 13.6 5.5 6.1
US
Healthequity Inc
NASDAQ:HQY
9.6B USD 7.8 79.1 25.7 42.8
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
19.9B BRL 1.2 -37.6 7.6 14.5
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.3 12.6 37.5
US
Progyny Inc
NASDAQ:PGNY
1.9B USD 1.6 36.6 21.7 22.8
P/E Multiple
Earnings Growth PEG
US
Clover Health Investments Corp
NASDAQ:CLOV
Average P/E: 22.9
Negative Multiple: -60.3 		N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
12.6
26%
0.5
US
A
Anthem Inc
LSE:0HG8
17.1
20%
0.9
US
Elevance Health Inc
NYSE:ELV
14.6
20%
0.7
US
Humana Inc
NYSE:HUM
16.4
30%
0.5
US
Centene Corp
NYSE:CNC
8
11%
0.7
US
Molina Healthcare Inc
NYSE:MOH
13.6
15%
0.9
US
Healthequity Inc
NASDAQ:HQY
79.1
69%
1.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -37.6 N/A N/A
US
M
Magellan Health Inc
F:MAH1
8.3
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
36.6
36%
1

See Also

Summary
CLOV intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLOV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLOV stock valuation using valuation multiples.
Wall Street Estimates
CLOV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLOV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 260,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.